Message Font: Serif | Sans-Serif
 
No. of Recommendations: 2
You cannot consider the launch of cometriq a failure until it has had a chance in the market. The earnings call was for q4 2012, approval was granted in late november. During the conference call it was stated that $0 revenue from cometriq was included since the first shipment of the drug was not delivered until january 2013. So, the earnings miss has nothing to do with the launch of the drug. I understand that you may be upset that you have invested in this company for so long with so little to show for it, but hang in there...this one will get legs in the next couple years or get bought out at a premium.
Print the post  

Announcements

When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.
Advertisement